Tennessee SB1767 seeks to prohibit the administration of mRNA pharmaceutical interventions, citing health concerns.
Tennessee SB1767, known as the "Tennessee mRNA Pharmaceutical Sovereignty and Safety Act," aims to amend Tennessee Code Annotated to prohibit the administration of mRNA pharmaceutical interventions. The bill cites numerous health concerns, including reproductive health issues, immune system disorders, neurological effects, cardiovascular risks, and other adverse events associated with mRNA vaccines. It defines "healthcare provider" and "mRNA vaccine or vaccine material," and imposes penalties for violations, including fines and potential administrative sanctions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.